Ellis Investment Partners, LLC Inovio Pharmaceuticals, Inc. Transaction History

Ellis Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.44 - $3.98 $2,880 - $7,960	-2,000 Reduced 33.33%	4,000 $6,000
Q1 2022 May 03, 2022	SELL	$2.97 - $5.2 $297 - $520	-100 Reduced 1.64%	6,000 $21,000
Q4 2021 Feb 01, 2022	BUY	$4.99 - $7.46 $9,980 - $14,920	2,000 Added 48.78%	6,100 $30,000
Q2 2021 Jul 26, 2021	BUY	$6.23 - $10.03 $12,460 - $20,060	2,000 Added 95.24%	4,100 $38,000
Q1 2021 May 03, 2021	BUY	$8.81 - $16.96 $881 - $1,696	100 Added 5.0%	2,100 $19,000
Q3 2020 Oct 19, 2020	BUY	$9.57 - $27.05 $9,570 - $27,050	1,000 Added 100.0%	2,000 $23,000
Q2 2020 Jul 13, 2020	BUY	$7.14 - $31.69 $7,140 - $31,690	1,000 New	1,000 $19,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $524M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.